| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/12/1999 | US5858976 Inhibiting tumor cell growth by administering dna for gene expression of a polypeptide fragment of p53, which regulates cell growth, capable of binding to novel human mdm2, a cancer-causing gene product that normally sequesters p53 |
| 01/12/1999 | US5858784 Aerosol transfecting agent |
| 01/12/1999 | US5858780 Cisplatin resistant cell line |
| 01/12/1999 | US5858776 Tumor cells with increased immunogenicity and uses therefor |
| 01/12/1999 | US5858775 Adeno-associated virus materials and methods |
| 01/12/1999 | US5858771 Nucleotide sequence coding full length human wild-type retinoblastoma protein used for gene therapy of individuals with predisposition for cancer by replacement of deactivated tumor suppressor gene; anticancer/antitumor agent |
| 01/12/1999 | US5858747 Control of cell growth in a bioartificial organ with extracellular matrix coated microcarriers |
| 01/12/1999 | US5858744 Gene transfer into stem cells |
| 01/12/1999 | US5858743 Delivery of nucleic acids |
| 01/12/1999 | US5858740 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells |
| 01/12/1999 | US5858726 Plasmid dna vectors for expression of viral capsid polypeptides and envelope glycoproteins from different virus species; producing self-assembling, non-replicating, non-infectious particles for vaccine and drug therapy |
| 01/12/1999 | US5858720 Hiss |
| 01/12/1999 | US5858718 Pcr a |
| 01/12/1999 | US5858716 H2CAA71 polynucleotides |
| 01/12/1999 | US5858708 For genetically engineered expression vectors in host cells, antisense molecules, and diagnosis and treatment of nervous system degenerative disorders such as amyotrophic lateral sclerosis |
| 01/12/1999 | US5858705 For cloning, gene therapy, and antagonists; anticarcinogenic/ antitumor/antiproliferative agents |
| 01/12/1999 | US5858701 DNA encoding an insulin receptor substrate |
| 01/12/1999 | US5858683 Determining presence of non-chromatin protein in biological sample (pap smears) by immunoassay or two-dimensional electrophoresis; accurate rapid diagnosis before metastasis occurs |
| 01/12/1999 | US5858674 Screening assays to identify agents that modulate cisplatin resistance |
| 01/12/1999 | US5858400 Co-administering an agent having large liposomes that include phospholipids substantially free of sterol |
| 01/12/1999 | US5858376 Introducing into cell isolated protein derived from herpes simplex virus |
| 01/12/1999 | US5858373 Recombinant poxvirus-feline infectious peritionitis virus, compositions thereof and methods for making and using them |
| 01/12/1999 | US5858355 Infecting in vitro cultured synovial cells with recombinant viral vector comprising dna sequence encoding interleukin-1 receptor antagonist protein linked to promoter, transplanting cells into arthritic joint space for expression |
| 01/12/1999 | US5858354 Repopulation of testicular Seminiferous tubules with foreign cells, corresponding resultant germ cells, and corresponding resultant animals and progeny |
| 01/12/1999 | US5858351 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors |
| 01/12/1999 | CA2117903C Targeted cleavage of rna using eukaryotic ribonuclease and external guide sequence |
| 01/10/1999 | CA2236493A1 Mura |
| 01/10/1999 | CA2236485A1 Novel 1spa |
| 01/09/1999 | CA2237158A1 Human semaphorin l (h-semal) and corresponding semaphorins in other species |
| 01/09/1999 | CA2205881A1 Tcr scfv and biological applications thereof |
| 01/08/1999 | CA2236473A1 Novel pcra |
| 01/08/1999 | CA2236468A1 Novel use |
| 01/08/1999 | CA2229464A1 Hfizg53 |
| 01/07/1999 | WO1999000516A2 Neuronal stem cell gene |
| 01/07/1999 | WO1999000511A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | WO1999000510A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 01/07/1999 | WO1999000507A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | WO1999000498A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | WO1999000494A2 Cell activation process and reagents therefor |
| 01/07/1999 | WO1999000491A1 Novel plasmid dna containing reporter gene dna and use of the same |
| 01/07/1999 | WO1999000422A1 Novel family of pheromone receptors |
| 01/07/1999 | WO1999000420A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | WO1999000419A1 Protein capable of combining with tbp to form complex, polynucleotide coding for said protein, anti-sense polynucleotide of said polynucleotide, and antibody capable of recognizing said protein |
| 01/07/1999 | WO1999000404A1 Secreted proteins |
| 01/07/1999 | WO1999000401A1 3'-monophosphorylating oligonucleotides |
| 01/07/1999 | WO1999000148A2 Method for treatment of spinal cord injuries in a mammal |
| 01/07/1999 | WO1999000146A1 Development and use of human pancreatic cell lines |
| 01/07/1999 | WO1999000144A1 Thermodynamic adaptive phased array system for activating thermosensititve liposomes in targeted drug delivery |
| 01/07/1999 | WO1999000071A1 Method for coating stents with dna and expression of recombinant genes from dna coated stent in vivo |
| 01/07/1999 | WO1998054213A3 Neurotrophic factor receptors |
| 01/07/1999 | WO1998042824A3 Methods for selecting cells and their uses |
| 01/07/1999 | WO1998040049A3 Specific magnetosome, method for the production and use thereof |
| 01/07/1999 | WO1998039464A3 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 01/07/1999 | WO1998039463A3 Lentivirus based vector and vector system |
| 01/07/1999 | WO1998035984A3 Compositions and methods for highly efficient transfection |
| 01/07/1999 | WO1998035048A3 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 01/07/1999 | WO1998032853A3 Secreted proteins and polynucleotides encoding them |
| 01/07/1999 | EP0889132A2 Streptococcus pneumoniae gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889131A2 Staphylococcus aureus gidA2 polynucleotides and polypeptides |
| 01/07/1999 | EP0889130A2 GidB polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889129A2 GidA1 polypeptides from Staphylococcus aureus |
| 01/07/1999 | EP0889128A2 midA1 polypeptides from Streptococcus pneumoniae |
| 01/07/1999 | EP0889127A1 Serine/threonine protein kinase (H-SGK2) |
| 01/07/1999 | EP0889126A2 YNL075W/HTXFT19 polypeptide |
| 01/07/1999 | EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase |
| 01/07/1999 | EP0889122A2 Inhibition of DNA Methyltransferase |
| 01/07/1999 | EP0889120A1 A micro-organism having reduced adaption to a particular environment |
| 01/07/1999 | EP0888545A1 Super-paramagnetic particles with increased r 1? relaxivity, processes for producing said particles and use thereof |
| 01/07/1999 | EP0888457A1 Adeno-associated virus vector for boosting immunogenicity of cells |
| 01/07/1999 | EP0888452A2 Extracellular matrix signalling molecules |
| 01/07/1999 | EP0888374A1 High affinity nucleic acid ligands of complement system proteins |
| 01/07/1999 | EP0888373A1 Smooth muscle cell lim protein |
| 01/07/1999 | EP0888370A1 Thyroid sodium/iodide symporter and nucleic acid encoding same |
| 01/07/1999 | EP0888128A2 Delivery of exogenous compounds |
| 01/07/1999 | EP0888123A2 Antagonism of endothelin actions |
| 01/07/1999 | EP0888054A1 Targeted site specific drug delivery compositions and method of use |
| 01/07/1999 | EP0888053A1 Method for treatment of cancer and infectious diseases and compositions useful in same |
| 01/07/1999 | EP0625195B1 Therapy of central nervous system by genetically modified cells |
| 01/07/1999 | CA2295925A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 01/07/1999 | CA2295315A1 Targeted gene transfer using g protein coupled receptors |
| 01/07/1999 | CA2295311A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 01/07/1999 | CA2295305A1 Neuronal stem cell gene |
| 01/07/1999 | CA2295303A1 Human nk-3 related prostate specific gene-1 |
| 01/07/1999 | CA2294473A1 Novel family of pheromone receptors |
| 01/06/1999 | CN1204369A Multi-functional hematopoietic receptor agonists |
| 01/06/1999 | CN1203948A Promoter of human endoglin gene and its use |
| 01/06/1999 | CN1203947A Promoter of cdc25B gene, its preparation and use |
| 01/06/1999 | CN1203919A 3'-monophosphorylated oligonucleotides |
| 01/05/1999 | US5856466 Coupling 2'-o-alkylated guanosine 3'-o-phosphoramidite with a 5'-hydroxyl moiety on an oligonucleotide |
| 01/05/1999 | US5856463 PSKH-1 ribozymes |
| 01/05/1999 | US5856435 Gene therapy; transferring nucleic acids |
| 01/05/1999 | US5856185 Method for making reflection defective retroviral vectors for infecting human cells |
| 01/05/1999 | US5856181 Cytopathic viruses for therapy and prophylaxis of neoplasia |
| 01/05/1999 | US5856171 Cell death regulators |
| 01/05/1999 | US5856169 Isolated nucleic acid |
| 01/05/1999 | US5856153 Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases |
| 01/05/1999 | US5856152 Transgenic supplying to cells |
| 01/05/1999 | US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase |
| 01/05/1999 | US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 01/05/1999 | US5856125 ETS2 repressor factor (ERF) genetic locus and its products |